IDO1 and systemic lupus erythematosus: Interestingly, inhibition of total IDO enzymatic activity via treatment with 1-d-MT, a tryptophan analog, accelerated the development of anti-nuclear autoantibodies (ANA) and glomerulonephritis (GN) in MRLlpr lupus-prone mice (18).